Holders over time
- DGX
- CI
| Quarter | DGX | CI |
|---|---|---|
| Q3 2020 | 18 holders, $1.0bn | 34 holders, $18.1bn |
| Q4 2020 | 21 holders, $1.1bn | 22 holders, $21.9bn |
| Q1 2021 | 19 holders, $1.2bn | 24 holders, $23.9bn |
| Q2 2021 | 14 holders, $975m | 31 holders, $22.5bn |
| Q3 2021 | 17 holders, $1.1bn | 30 holders, $17.8bn |
| Q4 2021 | 17 holders, $1.5bn | 26 holders, $20.1bn |
| Q1 2022 | 16 holders, $812m | 28 holders, $20.4bn |
| Q2 2022 | 16 holders, $813m | 32 holders, $22.1bn |
| Q3 2022 | 16 holders, $910m | 31 holders, $21.5bn |
| Q4 2022 | 13 holders, $1.1bn | 30 holders, $24.7bn |
| Q1 2023 | 17 holders, $989m | 35 holders, $18.2bn |
| Q2 2023 | 16 holders, $1.3bn | 30 holders, $19.8bn |
| Q3 2023 | 15 holders, $1.1bn | 28 holders, $19.8bn |
| Q4 2023 | 11 holders, $1.2bn | 31 holders, $20.6bn |
| Q1 2024 | 10 holders, $777m | 28 holders, $24.0bn |
| Q2 2024 | 13 holders, $1.2bn | 28 holders, $19.5bn |
| Q3 2024 | 11 holders, $1.7bn | 25 holders, $20.2bn |
| Q4 2024 | 9 holders, $1.6bn | 23 holders, $15.2bn |
| Q1 2025 | 10 holders, $1.8bn | 24 holders, $18.4bn |
| Q2 2025 | 10 holders, $2.4bn | 34 holders, $19.5bn |
| Q3 2025 | 13 holders, $2.5bn | 28 holders, $16.2bn |
| Q4 2025 | 10 holders, $1.5bn | 21 holders, $14.6bn |
| Q1 2026 | 9 holders, $1.6bn | 26 holders, $13.5bn |
| Q2 2026 | 7 holders, $1.6bn | 28 holders, $13.0bn |
Quest Diagnostics Inc
- Holders
- 10
- Reported value
- $1.8bn
- Buyers
- 7
- Sellers
- 3
Breadth +4 among 95 comparable managers.
The Cigna Group
- Holders
- 24
- Reported value
- $18.4bn
- Buyers
- 15
- Sellers
- 10
Breadth +5 among 95 comparable managers.
Who holds both, Q1 2025
Both (5)
AllianceBernstein LP, Bridgewater Associates LP, Neuberger Berman Group LLC, T. Rowe Price Associates Inc, Woodline Partners LP
Only DGX (5)
Balyasny Asset Management LLC, Caxton Associates LLP, First Eagle Investment Management LLC, Marshall Wace LLP, Wellington Management Group LLP
Only CI (19)
AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Glenview Capital Management LLC, Invesco Ltd, Man Group PLC, MFS Investment Management, Squarepoint Ops LLC, Susquehanna International Group LLP, Two Sigma Advisers LP, Two Sigma Investments LP, Winton Group Ltd
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.